Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I R Edwards

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Drug Safety|January 16, 1998
Causal or casual? The role of causality assessment in pharmacovigilanceR H Meyboom, Y A Hekster, A C Egberts, et al.
Journal of Chromatography|August 9, 1985
Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatographyL J Schaaf, D G Ferry, C T Hung, et al.
Pharmacoepidemiology and Drug Safety|January 1, 1996
Omeprazole and visual disorders: seeing alternativesM Lindquist, M Pettersson, I R Edwards, et al.
European Journal of Clinical Pharmacology|August 11, 1998
A Bayesian neural network method for adverse drug reaction signal generationA Bate, M Lindquist, I R Edwards, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Enhanced elimination of piroxicam by administration of activated charcoal or cholestyramineD G Ferry, L R Gazeley, W J Busby, et al.
Drug Safety|June 1, 1997
Principles of signal detection in pharmacovigilanceR H Meyboom, A C Egberts, I R Edwards, et al.
Pharmacology & Toxicology|May 1, 1997
How does cystitis affect a comparative risk profile of tiaprofenic acid with other non-steroidal antiinflammatory drugs? An international study based on spontaneous reports and drug usage data. ADR Signals Analysis Project (ASAP) TeamM Lindquist, M Pettersson, I R Edwards, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO systemM M Stahl, M Lindquist, M Pettersson, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Drug Safety|January 16, 1998
Causal or casual? The role of causality assessment in pharmacovigilanceR H Meyboom, Y A Hekster, A C Egberts, et al.
Journal of Chromatography|August 9, 1985
Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatographyL J Schaaf, D G Ferry, C T Hung, et al.
Pharmacoepidemiology and Drug Safety|January 1, 1996
Omeprazole and visual disorders: seeing alternativesM Lindquist, M Pettersson, I R Edwards, et al.
European Journal of Clinical Pharmacology|August 11, 1998
A Bayesian neural network method for adverse drug reaction signal generationA Bate, M Lindquist, I R Edwards, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Enhanced elimination of piroxicam by administration of activated charcoal or cholestyramineD G Ferry, L R Gazeley, W J Busby, et al.
Drug Safety|June 1, 1997
Principles of signal detection in pharmacovigilanceR H Meyboom, A C Egberts, I R Edwards, et al.
Pharmacology & Toxicology|May 1, 1997
How does cystitis affect a comparative risk profile of tiaprofenic acid with other non-steroidal antiinflammatory drugs? An international study based on spontaneous reports and drug usage data. ADR Signals Analysis Project (ASAP) TeamM Lindquist, M Pettersson, I R Edwards, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO systemM M Stahl, M Lindquist, M Pettersson, et al.
Pageof 12